<DOC>
	<DOCNO>NCT00978653</DOCNO>
	<brief_summary>In prospective study , investigator aim evaluate effect improve hyperuricemia , minor cardiovascular risk factor , endothelial dysfunction patient chronic kidney disease .</brief_summary>
	<brief_title>The Effect Uric Acid Decrement Endothelial Function Patients With Chronic Renal Failure</brief_title>
	<detailed_description>Endothelial dysfunction ( ED ) key event development atherosclerotic cardiovascular disease observe patient chronic kidney disease ( CKD ) . Experimental model show hyperuricemia cause hypertension renin angiotensin system activation . In prospective study , investigator aim evaluate effect improve hyperuricemia , minor cardiovascular risk factor , ED patient CKD .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hyperuricemia</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<mesh_term>Uric Acid</mesh_term>
	<criteria>Laboratory find hyperuricemia Patients age 18 60 year Nondiabetic patient Creatinine clearance value 20 60 mL/min/1.73 m2 Low ( &lt; 20 ml/min/1.73 m2 ) creatinine clearance , Patients diabetes mellitus , ischemic heart disease , acute coronary syndrome , congestive heart failure ( CHF ) ( New York Heart Association class II great ) , valvular heart disease history cerebral infarction transient ischemic attack . Patients take urate lowering medication ( allopurinol probenecid )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>allopurinol</keyword>
	<keyword>chronic kidney disease</keyword>
	<keyword>endothelial dysfunction</keyword>
	<keyword>hyperuricemia</keyword>
	<keyword>uric acid</keyword>
	<keyword>vascular endothelium</keyword>
	<keyword>xanthine oxidase inhibitor</keyword>
</DOC>